Expert Pitch

Will delay in results put an end to Iowa caucuses?

 Iowa State University
4-Feb-2020 5:05 PM EST, by Iowa State University

Newswise — AMES, Iowa – Karen Kedrowski, director of Iowa State University’s Catt Center for Women and Politics, says Iowa must justify its first-in-the-nation status every four years and the delay in results won’t help.  

“Detractors assert that Iowa is too old, too rural, too white and too agricultural to play such a crucial role in the presidential nomination process. Now they can point to this debacle as another reason Iowa should not go first: Iowa is simply in over its head.”

Kedrowski says Iowa’s influence historically has come from the momentum caucus winners receive from positive media attention, fundraising, endorsements and more.

“The winner or winners of the Iowa caucuses, whether by achieving a plurality of votes or by beating expectations, will not enjoy the same boost. Instead, their momentum will be diluted by this controversy and their names will always have an asterisk next to them, indicating that there was some controversy attached.”

Dave Peterson, professor of political science, says the delays may be a sign of what’s to come in November.  

“While there have clearly been errors, it is important to recognize they were made out of caution not malice. The Iowa Democratic Party is making a good faith effort to make sure there is an accurate count of the preferences of Iowa Democrats. Unfortunately, there is a tradeoff between accuracy and speed. The party’s commitment to transparency is the reason why it’s taking such care to not make a mistake.

“It is important for Americans to realize that we may very well be in the same position in November.  Arizona took a week to call it Senate race in 2018.  If that is the decisive state in the Electoral College, we could have a similar wait in 2020 with much higher stakes.  All of us need to go into that election expecting that we will not know the winner on election night.  The sanctity of our elections and our democracy depend on us valuing a correct count of the will of the voters more than an expediency.”

Iowa State University News Service has a broadcast studio on campus for live interviews. Please contact Dave Olson (515-294-5992, to make arrangements. 

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573